1.Grimble, RF (2001) Nutritional modulation of immune function. Proc Nutr Soc 60, 389–397.
2.Soeters, PB & Grimble, RF (2009) Dangers, and benefits of the cytokine mediated response to injury and infection. Clin Nutr 28, 583–596.
3.Phillips, A, Shaper, AG & Whincup, PH (1990) Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 2, 1434–1436.
4.Engeli, S, Feldpausch, M, Gorzelniak, K et al. (2003) Association between adiponectin and mediators of inflammation in obese women. Diabetes 52, 942–947.
5.Wolf, AM, Wolf, D, Rumpold, H et al. (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323, 630–635.
6.Hotamisligil, GS, Arner, P, Caro, JF et al. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95, 2409–2415.
7.Hotamisligil, GS, Budavari, A, Murray, D et al. (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94, 1543–1549.
8.Hotamisligil, GS & Spiegelman, BM (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271–1278.
9.Kern, PA, Saghizadeh, M, Ong, JM et al. (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95, 2111–2119.
10.Neels, JG & Olefsky, JM (2006) Inflamed fat: what starts the fire? J Clin Invest 116, 33–35.
11.Fasol, R, Schindler, M, Schumacher, B et al. (1992) The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac Cardiovasc Surg 40, 126–129.
12.Shor, R, Wainstein, J, Oz, D et al. (2008) Low HDL levels and the risk of death, sepsis and malignancy. Clin Res Cardiol 97, 227–233.
13.El-Solh, A, Sikka, P, Bozkanat, E et al. (2001) Morbid obesity in the medical ICU. Chest 120, 1989–1997.
14.Oliveros, H & Villamor, E (2008) Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity 16, 515–521.
15.Arvidsson, E, Viguerie, N, Andersson, I et al. (2004) Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 53, 1966–1971.
16.Allen, RD (1999) Polymorphism of the human TNFα promoter – random variation or functional diversity? Mol Immunol 36, 1017–1027.
17.Bidwell, J, Keen, L, Gallagher, G et al. (1999) Cytokine gene polymorphisms in human disease: on-line databases. Genes Immunity 1, 3–19.
18.Minihane, AM, Khan, S, Leigh-Firbank, EC et al. (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20, 1990–1997.
19.Andreassi, MG, Botto, N, Cocci, F et al. (2003) Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 112, 171–177.
20.Grimble, RF, Howell, WM, O'Reilly, G et al. (2002) The ability of fish oil to suppress tumor necrosis factor-alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes which influence TNFalpha production. Am J Clin Nutr 76, 454–459.
21.Jacob, CO, Fronek, Z, Lewis, GD et al. (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87, 1233–1237.
22.Messer, G, Spengler, U, Jung, MC et al. (1991) Polymorphic structure of the tumour necrosis factor (TNF) locus: an Nco I polymorphism in the first intron of the human TNFβ gene correlates with a variant amino acid in position 26 and a reduced level of TNFα production. J Exp Med 173, 209–219.
23.Jersmann, HP, Hii, CS, Ferrante, JV et al. (2001) Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways. Infect Immun 69, 1273–1279.
24.Ables, GP, Takamatsu, D, Noma, H et al. (2001) The roles of Nramp1 and Tnfa genes in nitric oxide production and their effect on the growth of Salmonella typhimurium in macrophages from Nramp1 congenic and tumor necrosis factor-alpha−/− mice. J Interferon Cytokine Res 21, 53–62.
25.Chernoff, AE, Granowitz, EV, Shapiro, L et al. (1995) A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154, 5492–5499.
26.Perrey, C, Pravica, V, Sinnott, PJ et al. (1998) Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transpl Immunol 6, 193–197.
27.Forsberg, L, Lyrenas, L, de Faire, U et al. (2001) A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 30, 500–505.
28.Mitrunen, K, Sillanpaa, P, Kataja, V et al. (2001) Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogen 22, 827–829.
29.Chorazy, PA, Schumacher, HR Jr & Edlind, TD (1992) Role of glutathione peroxidase in rheumatoid arthritis: analysis of enzyme activity and DNA polymorphism. DNA Cell Biol 11, 221–225.
30.Reid, CL, Hutchinson, IV, Campbell, IT et al. (1999) Genetic variation in cytokine production may be protective of ICU admission and may influence mortality. Clin Nutr 18, 45.
31.Mira, JP, Cariou, A, Grall, F et al. (1999) Association of TNF2, a TNFalpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282, 561–568.
32.Stuber, F, Petersen, M, Bokelmann, F et al. (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24, 381–384.
33.Jylhävä, J & Hurme, M (2009) Gene variants as determinants of longevity: focus on the inflammatory factors. Pflugers Arch 11 September 2009 (Epublication ahead of print).
34.Schroder, J, Kahlke, V, Book, M et al. (2000) Gender differences in sepsis: genetically determined? Shock 14, 307–310.
35.Thorell, A, Nygren, J, Ljungqvist, O et al. (2003) Cytokine genotype and gender influence the inflammatory response to surgery. Clin Nutr 22, S45.
36.Grimble, RF, Andersson, P, Madden, J et al. (2003) Gene:gene interactions influence the outcome in elderly patients. Clin Nutr 22, S39.
37.Persson, MD, Brismar, KE, Katzarski, KS et al. (2002) Nutritional status using mini nutritional assessment and subjective global assessment predict mortality in geriatric patients. J Am Geriatr Soc 50, 1996–2002.
38.Grimble, RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5, 551–559.
39.Nilsson, J, Jovinge, S, Niemann, A et al. (1998) Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 18, 1199–1202.
40.Yaqoob, P, Newsholme, EA & Calder, PC (1999) Comparison of cytokine production in cultures of whole blood and peripheral blood mononuclear cells. Cytokine 11, 600–605.
41.Markovic, O, O'Reilly, G, Fussell, HM et al. (2004) Role of single nucleotide polymorphisms of proinflammatory cytokine genes on the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males. Clin Nutr 23, 1084–1095.
42.Ohman, MK, Wright, AP, Wickenheiser, KJ et al. (2009) Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol 7, 169–179.
43.Hanley, AJ, Wagenknecht, LE, Norris, JM et al. (2009) Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia 52, 2079–2086.
44.Calder, PC (2001) Polyunsaturated fatty acids, inflammation and immunity. Lipids 36, 1007–1024.
45.Endres, S, Ghorbani, R, Kelley, VE et al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New Engl J Med 320, 265–271.
46.Madden, J, Brunner, A, Carrero, JJ et al. (2006) Polymorphisms at IL-6-174 and TNFα −308 and body mass index modulate the effects of fish oil supplementation on cytokine production by monocytes from healthy middle aged men. Proc Nutr Soc 65, 71A.
47.Mol, MJ, de Rijke, YB, Demacker, PN et al. (1997) Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 129, 169–176.
48.van Tits, LJ, Demacker, PN, de Graaf, J et al. (2000) Alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. Am J Clin Nutr 71, 458–464.
49.Devaraj, S & Jialal, I (2000) Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation. Circulation 102, 191–196.